Bortezomib

Bortezomib
Product Description

Manufacturing technology can be transfered.

Shiratori Pharmaceutical

  • Country/Region:
    Japan
  • On CPHI since:
    2020
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Primary activities
API Producer

Shiratori Pharmaceutical

  • Country/Region:
    Japan
  • On CPHI since:
    2020
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Primary activities
API Producer

More Products from Shiratori Pharmaceutical (4)

  • Brexpiprazole

    Product Brexpiprazole

    To be supplied to USA, EU and Japan.
  • Eltrombopag Olamine

    Product Eltrombopag Olamine

    Process validation is to be carried out soon.
  • Pemafibrate

    Product Pemafibrate

    To be supplied to USA, EU and Japan.
  • Tafamidis

    Product Tafamidis

    Process validation will be completed in early 2025.